추천 그룹에 게시된 게시물입니다.

As per Data Bridge Market Research analysis the omeprazole market was valued at USD 3.28 billion in 2025 and is projected to reach USD 4.28 billion by 2033, growing at a CAGR of 3.40% from 2026 to 2033.
The market is experiencing steady growth driven by the increasing prevalence of gastroesophageal reflux disease (GERD), peptic ulcers, and acid-related gastrointestinal disorders, along with rising demand for effective proton pump inhibitor (PPI) therapies across hospital and retail healthcare settings.
The growing aging population, increasing use of non-steroidal anti-inflammatory drugs (NSAIDs), and expanding access to generic pharmaceutical products are encouraging healthcare providers to prescribe omeprazole for long-term acid suppression and ulcer prevention, supporting continued market expansion.

